Ronald Forster, PhD Amgen, Inc.

Ronald Forster, PhD

Ronald Forster, PhD Amgen, Inc.

Dr. Forster is the Executive Director, CORE Engineering, Final Drug Product Technology department at Amgen Inc.  Head of all a diverse group of experts in mechanical, materials science, modeling, cold chain, and external engagement for combination/device products.  Prior to this role Ron was the Head of Primary Containers, Head of Advanced Devices (which identified Enbrel MiniDoser and Neulasta OBI devices), and numerous other roles.

He is also a Board of Director member as well as head of the Technical Advisory Committee for the Suzhou Industrial Park Biologics and Pharmaceutical Packaging institute, as well a Board Member of ELSIE.

Prior to joining Amgen,  Ron was with Merck Inc. where he was Senior Principle Engineer leading a group that implement Quality by Design for primary packaging systems from early clinical development  through  commercial supply chain systems.  He was a key leader in advancing the Merck Commercialization process and served as a global manufacturing lead on a key product franchise board.

During his tenure at Merck, he also served as an Adjunct Professor at Rutgers University in Biomedical Engineering and Ceramic Engineering.

Ron has an Interdisciplinary Ph.D. from Rutgers University in Chemical Engineering, Ceramic Engineering, and Mechanics and Materials Science.